Approval · Notice of Compliance 27402 · 2022
BENVYON: Notice of Compliance 27402
Issued January 14, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 27402
- Date
- January 14, 2022
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BENVYON | 02524309 | Marketed |
Medicinal ingredients
- BENDAMUSTINE HYDROCHLORIDE 25 MG per ML